نتایج جستجو برای: ژن hbsag

تعداد نتایج: 20716  

2017
Long Zhang Yuan-Yuan Wang Yan-Jie Huang Qiao-Mei Wang Kenrad E. Nelson An-Qi Wang Hai-Ping Shen Xiao-Li Liu Yi-Ping Zhang Dong-Hai Yan Zuo-Qi Peng Hong-Guang Zhang Ya Zhang Jun Zhao Yan Wang Ying Yang Yuan He Ji-Hong Xu Du-Jia Liu Tong-Jun Guo Xiao-Na Xin Hong Zhou Xu Ma

A cross-sectional analysis of prevalence of hepatitis B virus infection (HBV) among rural couples was conducted between 2010 and 2014. Serologic HBV markers, including hepatitis B surface antigen (HBsAg) and e antigen (HBeAg), were tested. Primary outcome of interest comprised HBsAg positivity in couples (both positive: F+M+, only wife positive: F+M-, only husband positive: F-M+), and secondary...

Journal: :BMJ 1988
M K Chan W K Chang

oestrogen therapy and protection from death from ischaemic heart disease. CH. A prospective study of postmenopausal estrogen therapy and coronary heart disease. Regulation of prosta-cyclin and thromboxane production by human umbilical vessels, the effect of estradiol and progesterone in a superfusion model. Prostaglandins Leukotrienes Med 1982;85:115. 31 Dyken ML, Wolf PA, Barnett HJM, et al. R...

2014
Min-Ran Li Hong-Li Xi Qin-Huan Wang Feng-Qin Hou Na Huo Xia-Xia Zhang Fang Li Xiao-Yuan Xu

BACKGROUND & AIMS About 350-400 million people are infected with hepatitis B virus (HBV) chronically and 1 million people die of hepatitis B virus (HBV)-related liver diseases. Nucleos(t)ide analogues (NAs) have been used for the treatment against HBV. However, few studies have investigated the long-term effects of different nucleos(t)ide analogues on levels of hepatitis B surface antigen (HBsA...

Journal: :Antiviral therapy 2013
Grace L-H Wong Henry L-Y Chan Angeline O-S Lo Hoi-Yun Chan Chi-Hang Tse Angel M-L Chim Vincent W-S Wong

BACKGROUND Kinetics of serum hepatitis B surface antigen (HBsAg) level in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B patients presented with severe reactivation and received oral antiviral therapy is unknown. We aimed to investigate the kinetics of HBsAg level among these patients. METHODS HBeAg-negative patients on antiviral therapy with follow-up for 2 years were studied. Th...

2011
Wen-cong Li Mao-rong Wang Ling-bo Kong Wei-guang Ren Yu-guo Zhang Yue-min Nan

BACKGROUND Interferon alpha (IFNα) therapy has been widely used in the treatment of chronic hepatitis B (CHB) for decades. Nucleos(t)ide analogues are also increasingly used to treat CHB recently. More and more studies are being carried out concerning the clearance or seroconversion of HBsAg, which is recognized as an ideal goal of CHB therapy. This study conducted a meta-analysis to estimate t...

Journal: :Prenatal diagnosis 1994
P M Grosheide H W Quartero S W Schalm R A Heijtink G C Christiaens

From 1982 to 1989, pregnant women in two large city hospitals in The Netherlands had serum samples screened for hepatitis B surface antigen (HBsAg). Infants of mothers found to be HBsAg-positive received hepatitis B immune globulin immediately after birth and hepatitis B vaccine in the first year of life. Blood samples of infants were regularly tested for HBsAg and antibodies directed against H...

2014
Kyun-Hwan Kim Hye-Young Chang Jun Yong Park Eun-Sook Park Yong Kwang Park Kwang-Hyub Han Sang Hoon Ahn

BACKGROUND/AIMS Occult HBV infection can persist following HBsAg loss and be transmitted, but the virological features are not well defined. METHODS Here we investigated 25 Korean patients who lost HBsAg during follow up, either spontaneously or subsequent to therapy. RESULTS Whereas subtype adr (genotype C) was found in 96% of HBsAg positive patients, 75 % of patients who lost HBsAg sponta...

2014
Jong Man Kim Hyojun Park Hye Ryoun Jang Jae Berm Park Choon Hyuck David Kwon Wooseong Huh Joon Hyeok Lee Sung Joo Kim Jae-Won Joh

PURPOSE HBsAg-positive kidney recipients are at increased risk for mortality and graft failure. The aims of this study were to identify the outcomes of HBsAg-positive recipients who received preemptive antiviral agents after successful kidney transplantation and to analyze risk factors for HBV reactivation. METHODS We retrospectively reviewed the medical records of 944 patients performed kidn...

Journal: :Journal of clinical microbiology 2013
Kazuhiko Takeda Mari Maruki Takahiro Yamagaito Machiko Muramatsu Yasuhiro Sakai Hiroaki Tobimatsu Hironori Kobayashi Yoshiteru Mizuno Yukio Hamaguchi

The performance of hepatitis B surface antigen (HBsAg) screening assays is continuously improved to reduce the risk of transfusion-associated hepatitis B. In this study, a semiautomated immune complex transfer chemiluminescence enzyme immunoassay (ICT-CLEIA) for the detection of HBsAg, which is as sensitive as hepatitis B virus (HBV) DNA PCR, was developed; the ICT-CLEIA assay performance was c...

Journal: :British medical journal 1985
P Wantzin J O Nielsen N Tygstrup H Soerensen E Dybkjaer

The profit to be gained by testing Danish blood donors for hepatitis B surface antigen (HBsAg) with a third generation technique instead of the currently used immunoelectrophoresis was investigated by additional screening of 48 750 blood units by radioimmunoassay three weeks after donation. Twenty nine units were positive for HBsAg on radioimmunoassay (0.059%). Only six of these were found by i...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید